DK0970073T3 - Fremgangsmåde til fremstilling af eprosartan - Google Patents

Fremgangsmåde til fremstilling af eprosartan

Info

Publication number
DK0970073T3
DK0970073T3 DK98906229T DK98906229T DK0970073T3 DK 0970073 T3 DK0970073 T3 DK 0970073T3 DK 98906229 T DK98906229 T DK 98906229T DK 98906229 T DK98906229 T DK 98906229T DK 0970073 T3 DK0970073 T3 DK 0970073T3
Authority
DK
Denmark
Prior art keywords
eprosartan
preparation
Prior art date
Application number
DK98906229T
Other languages
Danish (da)
English (en)
Inventor
Joseph Robert Flisak
Li Liu
Clifford S Labaw
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DK0970073T3 publication Critical patent/DK0970073T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
DK98906229T 1997-02-14 1998-02-13 Fremgangsmåde til fremstilling af eprosartan DK0970073T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3819597P 1997-02-14 1997-02-14
PCT/US1998/002412 WO1998035963A1 (en) 1997-02-14 1998-02-13 Process for preparing eprosartan

Publications (1)

Publication Number Publication Date
DK0970073T3 true DK0970073T3 (da) 2005-02-21

Family

ID=21898583

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98906229T DK0970073T3 (da) 1997-02-14 1998-02-13 Fremgangsmåde til fremstilling af eprosartan

Country Status (41)

Country Link
US (1) US6172237B1 (ja)
EP (1) EP0970073B1 (ja)
JP (1) JP4537499B2 (ja)
KR (1) KR100573638B1 (ja)
CN (1) CN1085208C (ja)
AP (1) AP1128A (ja)
AR (1) AR011125A1 (ja)
AT (1) ATE280765T1 (ja)
AU (1) AU730383B2 (ja)
BG (1) BG63804B1 (ja)
BR (1) BR9808664A (ja)
CA (1) CA2281708C (ja)
CO (1) CO4950550A1 (ja)
CY (1) CY2555B1 (ja)
CZ (1) CZ296349B6 (ja)
DE (1) DE69827240T2 (ja)
DK (1) DK0970073T3 (ja)
EA (1) EA001659B1 (ja)
EG (1) EG23935A (ja)
ES (1) ES2231963T3 (ja)
HU (1) HU228781B1 (ja)
ID (1) ID23181A (ja)
IL (1) IL131309A (ja)
IN (2) IN187999B (ja)
MA (1) MA24470A1 (ja)
MY (1) MY118704A (ja)
NO (1) NO317194B1 (ja)
NZ (1) NZ337180A (ja)
OA (1) OA11146A (ja)
PE (1) PE59299A1 (ja)
PL (1) PL192838B1 (ja)
PT (1) PT970073E (ja)
RO (1) RO119719B1 (ja)
SA (1) SA98190082B1 (ja)
SI (1) SI0970073T1 (ja)
SK (1) SK285036B6 (ja)
TR (1) TR199901936T2 (ja)
TW (1) TW399050B (ja)
UA (1) UA54487C2 (ja)
WO (1) WO1998035963A1 (ja)
ZA (1) ZA981207B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100137613A1 (en) * 2006-12-27 2010-06-03 Hetero Drugs Limited Process for eprosartan
EP2181109A4 (en) * 2007-07-25 2011-08-03 Hetero Drugs Ltd CRYSTALLINE PARTICLES OF EPROSARTAN MESYLATE AND PROCESS FOR PREPARING PURE EPROSARTAN
EP2295431A3 (en) * 2007-07-25 2011-08-03 Hetero Drugs Limited Substantially pure eprosartan free base
WO2009084028A2 (en) * 2007-12-03 2009-07-09 Neuland Laboratories Ltd Improved process for manufacturing anhydrous (e)-3-[2-butyl-1- {(4-carboxyphenyl) methyl}-1h-imidazole-5-yl]-(thiophen-2- ylmethyl)prop-2-enoic acid methane sulfonate
CN101215284B (zh) * 2007-12-31 2010-10-13 浙江华海药业股份有限公司 一种改进的依普罗沙坦的制备方法
US20110054186A1 (en) * 2008-03-31 2011-03-03 Hetero Research Foundation Process for eprosartan intermediate
WO2010023688A2 (en) * 2008-08-25 2010-03-04 Matrix Laboratories Limited An improved process for the preparation of eprosartan
WO2011004384A2 (en) 2009-06-05 2011-01-13 Glochem Industries Limited Process for the preparation of eprosartan
WO2011051975A1 (en) 2009-10-30 2011-05-05 Matrix Laboratories Ltd An improved process for the preparation of pure eprosartanand its pharmaceutical acceptable salts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
AU9137791A (en) * 1990-12-14 1992-07-08 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
US5395847A (en) * 1993-12-02 1995-03-07 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
EP0850225B1 (en) * 1994-05-20 2003-08-13 Smithkline Beecham Corporation Intermediate for preparing a pharmaceutically active compound

Also Published As

Publication number Publication date
SI0970073T1 (en) 2005-02-28
ATE280765T1 (de) 2004-11-15
DE69827240D1 (de) 2004-12-02
BR9808664A (pt) 2000-07-11
PL192838B1 (pl) 2006-12-29
JP4537499B2 (ja) 2010-09-01
CN1085208C (zh) 2002-05-22
AU730383B2 (en) 2001-03-08
CZ285299A3 (cs) 2000-02-16
AP9901620A0 (en) 1999-09-30
CY2555B1 (en) 2008-07-02
IN192743B (ja) 2004-05-15
JP2001510466A (ja) 2001-07-31
EA199900740A1 (ru) 2000-02-28
NZ337180A (en) 2000-11-24
CA2281708C (en) 2007-08-14
ZA981207B (en) 1998-11-12
BG63804B1 (bg) 2003-01-31
HUP0001994A2 (hu) 2001-06-28
PE59299A1 (es) 1999-09-09
HUP0001994A3 (en) 2001-07-30
HU228781B1 (en) 2013-05-28
EP0970073A4 (en) 2001-01-24
NO993913D0 (no) 1999-08-13
TR199901936T2 (xx) 2000-04-21
NO317194B1 (no) 2004-09-13
ES2231963T3 (es) 2005-05-16
DE69827240T2 (de) 2005-10-13
OA11146A (en) 2003-04-16
IL131309A0 (en) 2001-01-28
WO1998035963A1 (en) 1998-08-20
IL131309A (en) 2002-09-12
SK285036B6 (sk) 2006-05-04
MY118704A (en) 2005-01-31
EP0970073A1 (en) 2000-01-12
EG23935A (en) 2008-01-14
ID23181A (id) 2000-03-23
PT970073E (pt) 2005-02-28
UA54487C2 (uk) 2003-03-17
CO4950550A1 (es) 2000-09-01
SK108799A3 (en) 2000-05-16
CN1247539A (zh) 2000-03-15
AR011125A1 (es) 2000-08-02
MA24470A1 (fr) 1998-10-01
PL335075A1 (en) 2000-04-10
BG103650A (en) 2000-06-30
US6172237B1 (en) 2001-01-09
IN187999B (ja) 2002-08-03
EA001659B1 (ru) 2001-06-25
AU6150898A (en) 1998-09-08
AP1128A (en) 2002-12-06
NO993913L (no) 1999-08-13
KR100573638B1 (ko) 2006-04-26
TW399050B (en) 2000-07-21
CZ296349B6 (cs) 2006-02-15
RO119719B1 (ro) 2005-02-28
CA2281708A1 (en) 1998-08-20
KR20000071007A (ko) 2000-11-25
EP0970073B1 (en) 2004-10-27
SA98190082B1 (ar) 2006-08-20

Similar Documents

Publication Publication Date Title
DK1032566T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1123284T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1038008T3 (da) Fremgangsmåde til fremstilling af EGIII-lignende enzymer
DK1173431T4 (da) Fremgangsmåde til fremstilling af citalopram
DK1105382T3 (da) Fremgangsmåde til fremstilling af citalopram
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
DK1159274T3 (da) Fremgangsmåde til fremstilling af citalopram
DK0747116T3 (da) Fremgangsmåde til fremstilling af mikrokapselsammensætninger
DK1005517T3 (da) Fremgangsmåde til fremstilling af diglycerider
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DK1053217T3 (da) Fremgangsmåde til fremstilling af n-propanol
DK1027315T3 (da) Fremgangsmåde til fremstilling af n-butanol
DK0996642T3 (da) Fremgangsmåde til fremstilling af heparin
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK0966444T3 (da) Fremgangsmåde til fremstilling af pyrazolderivater
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0970939T3 (da) Fremgangsmåde til fremstilling af methanol
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK0927766T3 (da) Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner
DK0985733T3 (da) Fremgangsmåde til fremstilling af cyclodextrin
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK1298124T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer